Researchers Quantify Magnitude of Cardiovascular Risk Associated With Cannabis
By Elana Gotkine HealthDay Reporter
WEDNESDAY, June 18, 2025 -- Cannabis use is associated with major adverse cardiovascular events (MACE), according to a systematic review based on real-world data published online June 17 in Heart.
Wilhelm Storck, from the University of Toulouse in France, and colleagues examined the possible association between MACE and the use of cannabis or cannabinoids in a review of pharmacoepidemiological studies published from Jan. 1, 2016, to Jan. 31, 2023. Twenty-four articles, including 17 cross-sectional studies, six cohort studies, and one case-control study, were reviewed.
In all studies, exposure corresponded to use of cannabis, with one study focused on medical cannabis. The researchers found that the estimated risk ratios were 1.29, 1.20, and 2.10 for nonfatal acute coronary syndrome (ACS), stroke, and cardiovascular death, respectively. No significant association was seen for the composite outcome combining ACS and stroke as measured in two studies. Results for the focused analysis restricted to cohort studies were comparable to the primary model (risk ratio, 1.32).
"Cannabis needs to be incorporated into the framework for prevention of clinical cardiovascular disease," write the authors of an accompanying editorial. "Cardiovascular and other health risks must be considered in the regulation of allowable product and marketing design as the evidence base grows. Today that regulation is focused on establishing the legal market with woeful neglect of minimizing health risks. Specifically, cannabis should be treated like tobacco: not criminalized, but discouraged, with protection of bystanders from secondhand exposure."
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Marine Microplastic Levels Linked to Cardiometabolic Disease Prevalence
WEDNESDAY, June 18, 2025 -- In coastal counties, marine microplastic levels (MMLs) are associated with the prevalence of cardiometabolic diseases, according to a study published...
DASH Diet for Diabetes With Low Sodium Reduces BP in Those With Diabetes
WEDNESDAY, June 18, 2025 -- The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in...
Prenatal PFAS Exposure Linked to Elevated BP Through Adolescence
MONDAY, June 16, 2025 -- Prenatal exposure to specific perfluoroalkyl and polyfluoroalkyl substances (PFAS) is associated with offspring blood pressure (BP) through age 18 years...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.